In previous studies, it has been shown that a new mouse model can lead to excessive activation of NLRP3 inflammatory bodies in hepatocytes, thereby shortening the survival period of mice and causing poor growth and severe liver inflammation. This evidence concerns the gene NLRP3 and digestive system neoplasm.